Back to
MORGAN STANLEY
CRVSShowing 8 of 9 quarters
Position history for
MORGAN STANLEY's holdings in CORVUS PHARMACEUTICALS INC
Yes. Morgan Stanley holds 1,344,736 shares of CRVS (Corvus Pharmaceuticals), worth $20.1M, as of its Q2 2026 13F filing. It reduced the position by 1,154,089 shares (-46.2%) from Q1 2026. Morgan Stanley has held CRVS in every 13F on record since Q2 2024, 9 quarterly filings.
Current Value
$20.1M
Current Shares
1.3M
Total Value Change
+$18M
Total Shares Change
+951,474
Quarter-by-Quarter History
Other major holders of CRVS: BlackRock, Inc., STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/